Tag Archives: opioid abuse

June, 2017

9 June
FDA Requests Removal of Opana ER for Risks Related to Abuse

Today, the U.S. Food and Drug Administration requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market. After careful consideration, the agency is seeking removal based on its concern that the benefits of the drug may no longer outweigh its risks. This is …
Share

16 March
CDC Releases Guideline for Prescribing Opioids for Chronic Pain

As part of the U.S. government’s urgent response to the epidemic of overdose deaths, the Centers for Disease Control and Prevention (CDC) today is issuing new recommendations for prescribing opioid medications for chronic pain, excluding cancer, palliative, and end-of-life care. The CDC Guideline for Prescribing Opioids for Chronic Pain, United …
Share

5 February
Califf, FDA Top Officials Call for Sweeping Review of Agency Opioids Policies

SILVER SPRING, Md., Feb. 4, 2016 /PRNewswire-USNewswire/ — In response to the opioid abuse epidemic, today Dr. Robert Califf, the FDA’s Deputy Commissioner for Medical Products and Tobacco, along with other FDA leaders, called for a far-reaching action plan to reassess the agency’s approach to opioid medications. The plan will …
Share